NKTXMICRO

Nkarta, Inc.

HealthcareBiotechnology
$2.85
$0.00(+0.71%)
52W$1.63
$3.65
Updated Jun 29, 02:00 AM
RSI51
RS Rating76/99
Beta2.15
Volatility73%
F-Score2/9
Mkt Cap$204M
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Nkarta, Inc. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is moderate (RS Rating: 76), indicating performance broadly in line with the market. Earnings growth of 14% provides fundamental context to the price action. Investors should exercise caution due to high volatility (73% annualized), which requires wider risk management.

Relative Strength
76
out of 99
Average
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
2.15
vs S&P 500
HIGH BETA
52W Position
60%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$2.92
50 SMA > 100 SMA$2.60
100 SMA > 150 SMA$2.39
150 SMA > 200 SMA$2.32

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$2.75+3.62%ABOVE
50 SMA$2.92-2.40%BELOW
100 SMA$2.60+9.48%ABOVE
150 SMA$2.39+19.03%ABOVE
200 SMA$2.32+22.74%ABOVE

Price Performance

1D+0.7%
1W+2.2%
1M-12.3%
3M+42.5%
6M+54.1%
YTD+52.4%
1Y+71.7%
3Y+6.9%
52-Week Trading Range60% from low
$2.85
52W Low$1.63
52W High$3.65

Technical Indicators

RSI (14)NEUTRAL
50.6
305070
Setup ScoreCOOL
3/10
Base depth: 53.3%

Risk Profile

Beta
2.15
52W Vol
73%
ATR
$0.23
Max DD (1Y)
-34%

Volume Analysis

Today
570.7K
50D Avg
686.0K
Vol Ratio
0.83x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25+9%
$-0.31
Q3'25+26%
$-0.29
Q4'25-6%
$-0.37
Q1'26+14%
$-0.37
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+11.26%

Stock Price CAGR

10 Years:-24.59%
5 Years:-37.41%
3 Years:+6.95%
1 Year:+71.69%

Return on Equity

10Y Avg:-37.6%
5Y Avg:-32.8%
3Y Avg:-32.4%
Last Year:-30.9%

Key Metrics

Market Cap$204M
Gross Margin
Net Margin
Piotroski F-Score2/9

Frequently Asked Questions

Is NKTX in an uptrend right now?

NKTX has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is NKTX overbought or oversold?

NKTX's RSI (14) is 51. The stock is in neutral territory, neither overbought nor oversold.

Is NKTX outperforming the market?

NKTX has a Relative Strength (RS) Rating of 76 out of 99. NKTX is performing about average compared to the market.

Where is NKTX in its 52-week range?

NKTX is trading at $2.85, which is 78% of its 52-week high ($3.65) and 60% above its 52-week low ($1.63).

How volatile is NKTX?

NKTX has a Beta of 2.15 and 52-week volatility of 73%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.